文献速递中枢神经肿瘤放疗头颈部肿瘤放疗胸部肿瘤放疗

PET显像在临床放射肿瘤学中的新进展

Recent advances of PET imaging in clinical radiation oncology.
PubMed 文献 · Radiat Oncol · 2020-04-21

本文综述PET显像在临床放射肿瘤学中的近期进展,涵盖神经肿瘤、头颈癌、肺癌、消化道肿瘤及前列腺癌。PET可在分子水平可视化和量化肿瘤代谢或受体表达,用于放疗靶区勾画、疗效评估、失败模式预测及剂量递增区域定义,弥补常规形态学成像的不足。

要点

  • PET可在分子水平显示肿瘤代谢或受体表达,补充CT/MRI形态学信息。
  • PET用于放疗靶区勾画、治疗中及治疗后疗效评估、失败模式预测和剂量递增区定义。
  • 综述覆盖神经肿瘤、头颈癌、肺癌、消化道肿瘤和前列腺癌的放疗计划与预后。

核心结论

  • PET显像在放疗患者管理中临床意义日益增加,可提供超越形态学范围的分子水平肿瘤特征。

研究设计与样本

  • 本文为综述,聚焦PET显像在临床放疗/放射肿瘤学中神经肿瘤、头颈癌、肺癌、消化道肿瘤及前列腺癌的近期与当前进展。

主要发现

  • PET衍生的肿瘤代谢或受体表达信息可用于肿瘤范围可视化、治疗中及治疗后疗效评估、失败模式预测和剂量递增区定义。

临床怎么用

  • 在常规CT/MRI形态学成像无法充分回答诊断问题时,PET可用于辅助放疗靶区勾画、疗效评估和预后判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radiotherapy and radiation oncology play a key role in the clinical management of patients suffering from oncological diseases. In clinical routine, anatomic imaging such as contrast-enhanced CT and MRI are widely available and are usually used to improve the target volume delineation for subsequent radiotherapy. Moreover, these modalities are also used for treatment monitoring after radiotherapy. However, some diagnostic questions cannot be sufficiently addressed by the mere use standard morphological imaging. Therefore, positron emission tomography (PET) imaging gains increasing clinical significance in the management of oncological patients undergoing radiotherapy, as PET allows the visualization and quantification of tumoral features on a molecular level beyond the mere morphological extent shown by conventional imaging, such as tumor metabolism or receptor expression. The tumor metabolism or receptor expression information derived from PET can be used as tool for visualization of tumor extent, for assessing response during and after therapy, for prediction of patterns of failure and for definition of the volume in need of dose-escalation. This review focuses on recent and current advances of PET imaging within the field of clinical radiotherapy / radiation oncology in several oncological entities (neuro-oncology, head & neck cancer, lung cancer, gastrointestinal tumors and prostate cancer) with particular emphasis on radiotherapy planning, response assessment after radiotherapy and prognostication.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Unterrainer M, Eze C, Ilhan H, et al. Recent advances of PET imaging in clinical radiation oncology. Radiat Oncol. 2020. PMID: 32317029. doi:10.1186/s13014-020-01519-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。